Limitations of SARC-F As a Screening Tool for Sarcopenia in Patients on Hemodialysis
Overview
Authors
Affiliations
Introduction: There are limited screening tools for sarcopenia in patients undergoing hemodialysis. This study aimed to investigate the reliability and validity of the SARC-F (Strength, Assistance in walking, Rise from a chair, Climb stairs, and Falls) questionnaire as a screening tool for sarcopenia (defined by the Asian Working Group for Sarcopenia [AWGS2019]) in patients undergoing hemodialysis.
Methods: This cross-sectional study enrolled 179 patients (mean age: 66.5 ± 12 years, 58% men) undergoing maintenance hemodialysis 3 times per week at a hemodialysis center in Japan. The SARC-F score, handgrip strength, usual gait speed, sit-to-stand test time, short physical performance battery (SPPB), and appendicular skeletal muscle mass were evaluated. The reliability and validity of the SARC-F were analyzed using receiver-operating characteristic curve, area under the curve (AUC), and sensitivity/specificity analyses.
Results: There were 49 (27.4%) patients with sarcopenia. Patients with SARC-F ≥4 (59 patients, 33.0%) had poorer grip strength, lower SPPB score, and slower gait speed than those with SARC-F <4, while the skeletal muscle mass index did not differ significantly between the two groups. The sensitivity and specificity values of the SARC-F for identifying sarcopenia were 42.9% and 70.8%, respectively, while those for identifying severe sarcopenia were 66.7% and 72.3%, respectively. The AUCs of SARC-F were 0.57 for sarcopenia and 0.70 for severe sarcopenia.
Discussion/conclusion: The SARC-F alone is an inadequate screening tool for sarcopenia in patients undergoing hemodialysis. It should be used in combination with objective assessment measures, rather than as a first-step screening tool, to diagnose sarcopenia.
Vanitcharoenkul E, Unnanuntana A, Chotiyarnwong P, Adulkasem N, Asavamongkolkul A, Laohaprasitiporn P BMC Geriatr. 2024; 24(1):1043.
PMID: 39732657 PMC: 11681680. DOI: 10.1186/s12877-024-05637-3.
Borges S, Fortes R, Martins T, Lopes Alves M, Cipriano Jr G, Cipriano G Sci Rep. 2024; 14(1):23262.
PMID: 39370431 PMC: 11456598. DOI: 10.1038/s41598-024-74412-6.
Katalinic L, Juric I, Furic Cunko V, Premuzic V, Jelakovic B, Basic-Jukic N J Clin Med. 2024; 13(18).
PMID: 39337040 PMC: 11432496. DOI: 10.3390/jcm13185554.
Comparative evaluation of screening tools for sarcopenia in patients with axial spondyloarthritis.
Chaiamnuay S, Kanjanavaikoon N, Saisirivechakun P Sci Rep. 2024; 14(1):14407.
PMID: 38909047 PMC: 11193750. DOI: 10.1038/s41598-024-65120-2.
Duarte M, Pereira M, Baiao V, Vieira F, Silva M, Krug R BMC Nephrol. 2023; 24(1):239.
PMID: 37582699 PMC: 10428584. DOI: 10.1186/s12882-023-03168-4.